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ABSTRACT 
The I-κB kinase (IKK) subunit 
NEMO/IKKγ (NEMO) is an adapter molecule that 
is critical for canonical activation of NF-κB, a 
pleiotropic transcription factor controlling 
immunity, differentiation, cell growth, 
tumorigenesis and apoptosis. To explore the 
functional role of canonical NF-κB signaling in 
thyroid gland differentiation and function, we 
have generated a murine strain bearing a genetic 
deletion of the NEMO locus in thyroid. Here we 
show that thyrocyte-specific NEMO knockout 
mice gradually develop hypothyroidism after 
birth, which leads to reduced body weight and 
shortened life span. Histological and molecular 
analysis indicate that  absence of NEMO in 
thyrocytes results in a dramatic loss of the thyroid 
gland cellularity, associated with down-regulation 
of thyroid differentiation markers and ongoing 
apoptosis. Thus, NEMO-dependent signaling is 
essential for normal thyroid physiology. 
________________________________________ 
 
INTRODUCTION 
The nuclear factor (NF)-κB signaling pathway 
controls a variety of important biological 
functions, including immune and inflammatory 
responses, differentiation, cell growth, 
tumorigenesis and apoptosis (1). Two distinct 
pathways of NF-κB activation have been reported. 
The classical, canonical pathway is found 
virtually in all mammalian cells and depends on 
the presence of the IKKγ/NF-κB essential 
modulator (NEMO) protein (1). In this pathway, 
NF-κB activation is mediated by the IKK 
complex, consisting of the IKK1/IKKα and 
IKK2/IKKβ catalytic kinase subunits and the 
NEMO regulatory protein (1). Basically, NF-κB 
transcription factors are kept inactive in the 
cytoplasm through binding to members of the I-
κB family of inhibitory proteins. Cell activation 
by a variety of stimuli results in the IKK-
dependent phosphorylation of  I-κB proteins, 
followed by their polyubiquitination and their 
proteasome-dependent degradation, allowing NF-
κB dimers to enter the nucleus and catalyze 
transcription of target genes (1). In specific 
lymphoid tissues cells, an alternative, non-
canonical pathway has been described that relies 
on IKKα-mediated phosphorylation of I-κB 
molecules. This pathway seems to be independent 
of NEMO activity (1). Recent publications have 
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also shown that diverse posttranslational 
modifications, including ubiquitination, 
sumoylation and phosphorylation, regulate the 
function of NEMO in the IKK complex (2-6). 
 
 
 Gene-targeting experiments have shown 
that mice lacking p65/RelA, IKK2/IKKβ, or 
NEMO die during embryonic development due to 
liver apoptosis (7-12). The evidence that NEMO-
deficient mice exhibit a phenotype similar to that 
of p65/RelA-deficient mice demonstrates the 
essential role of NEMO in the canonical NF-κB 
signaling. Experiments based on tissue- and/or 
organ-specific deletion of NEMO, obtained 
through Cre-mediated genetic recombination, 
have given diverse results regarding the 
physiological role of this protein. In fact, ablation 
of NEMO in liver parenchymal cells causes 
spontaneous development of steatohepatitis and 
hepatocellular carcinoma (13). Instead, intestinal 
epithelial-cell-specific deletion of NEMO results 
in severe chronic intestinal inflammation due to 
apoptosis of colonic epithelial cells, impaired 
expression of antimicrobial peptides and 
translocation of bacteria into the mucosa (14). 
Central nervous system-specific ablation of 
NEMO results in no apparent abnormalities, but 
rather ameliorates inflammatory and autoimmune 
pathologies (15). NEMO inactivation in the heart 
did not affect embryonic cardiac development but 
led to spontaneous and progressive impairment of 
cardiac function, progression to dilated 
cardiomyopathy and heart failure (16). Finally, 
genetic abrogation of NEMO in podocytes did not 
affect normal glomerular development and 
function under non-stressed conditions (17). Thus, 
it appears that canonical NF-κB signaling 
performs different roles and functions depending 
on the type of tissue and organ. 
In the present work, we have investigated 
the requirement for NEMO in thyroid 
development, differentiation and function by 
generating a mouse model bearing a thyroid-
specific genetic inactivation of NEMO. In these 
mice, development and differentiation of the 
thyroid gland appears normal. In contrast, after 
birth, thyroid-specific NEMO knockout mice 
develop progressive loss of thyroid cellularity and 
thyroid markers, hypothyroidism and reduced 
vitality due to extensive apoptosis of thyroid cells. 
Thus, our data indicate that NF-κB-dependent 
gene expression is essential for maintaining 
normal thyroid gland structure and function in the 
adult. 
 
 
 
EXPERIMENTAL PROCEDURES 
 
Ethics Procedures involving animals were 
conducted as indicated in the Italian National 
Guidelines (D.L. No. 100/2006, and D.L. No. 
116/1992) and in the pertinent European 
Directives (EEC Council Directive 86/609, 
1.12.1987), adhering to the Guide for the Care and 
Use of Laboratory Animals (United States 
National Research Council, 1996). All the in vivo 
experimental activities were approved by the 
Animal Ethics Committee (CESA) of Biogem 
(Italy) with ID no. 4713. 
 
Generation of NEMOTS-KO mice 
To inactivate the NEMO gene in thyroid, mice 
expressing Cre recombinase under the control of 
endogenous Pax8 promoter (18) and NEMOFlox/+ 
(12) were bred. NEMOFlox/Y/Pax8Cre/+ mice were 
named NEMOTS-KO and used as the experimental 
group, while NEMO+/Y/Pax8Cre/+ littermates were 
used as controls (CTR). Genotyping was 
performed by PCR analysis of tail biopsy. All 
experiments were conducted on age and gender-
matched animals. 
 
Metabolic measurements 
Renal parameters were evaluated in 12-month-old 
mice using  metabolic cages as previously 
described (19). Mice were housed individually in 
metabolic cages for 5 days at 23° C with  12 hrs 
dark/light cycle. After 4 days of adjustment, 
parameters were registered  on day 5. 24 hrs urine 
output was collected under mineral oil to prevent 
evaporation. Proteinuria was quantified by 
Bradford assay, urinary electrolytes and creatinine 
were evaluated using Vitrovet (Scil). 
 
Histology and Immunohistochemistry 
Mice were anesthetized by isoflurane and 
perfused through abdominal aorta with 4% PFA. 
Blood, left kidney and thyroid were collected 
before perfusion. The left kidney and one thyroid 
lobe were used for immunoblotting or PCR, while 
the right kidney and the other thyroid lobe were 
used for immunohistochemistry. After embedding 
in paraffin, 4 µm thick sections were stained with 
hematoxylin and eosin (Sigma-Aldrich) or with 
Masson's trichrome kit (Bio-Optica). For 
immunohistochemistry, sections were incubated 
overnight in xylene and then progressively in 
ethanol solution (99%-96%-70%). Endogenous 
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peroxidase activity was quenched with 35% H2O2 
in methanol and target retrieval was performed in 
TEG buffer pH 9.2. Primary antibodies were 
incubated overnight at 4° C, sections were then 
incubated with secondary anti-rabbit HRP-
conjugated antibody (Dako). Chromogenic 
reactions were carried out with DAB (Vector 
Laboratories) and stained sections were mounted 
with Eukitt (Bio-Optica).  
For immunofluorescence analysis, thyroid 
sections were incubated overnight at 4°C with 
anti-Nis antibody (gently provided by Prof. De 
Felice). Sections was then incubated with 
secondary anti-rabbit conjugated Alexa Fluor 488; 
DAPI was used as nuclear counterstain. The 
primary antibodies used for kidney staining were: 
anti AQP2 and anti NKCC2 were provided by 
Prof. Frische; anti-Pax8, anti-Titf1 and anti- 
thyroglobulin were provided by Prof. De Felice; 
anti-cleaved Caspase-3 was purchased from Cell 
Signalling Technology. Zeiss Axioplan 2 
microscope was used for images acquisition. 
All stainings were done al least three times using 
different biological material sources. 
 
Immunoblotting 
Tissues were homogenized with a TissueLyser 
(Qiagen) in lysis buffer (300 mM sucrose; 25 mM 
imidazole; 1mM EDTA, 1mM PMSF) with 
protease and phosphatase inhibitor cocktails 
(Roche). Immunoblottings were performed as 
previously described (20). Briefly, extracted 
proteins were separated by SDS-PAGE, 
transferred onto nitrocellulose membrane and 
incubated with primary antibodies followed by 
horseradish peroxidase-conjugated secondary 
antibodies (Amersham Biosciences). Blots were 
developed using the ECL system (Amersham 
Biosciences). Anti NEMO, anti IKKα/β, anti p65, 
anti p50, anti phospho-CREB, anti CREB, anti 
Caspase 3 and anti β-actin antibodies were 
obtained from Santa Cruz Biotechnology. All 
immunoblots were done al least three times using 
different biological material sources.  
 
RNA extraction and qPCR 
1 µg of total RNA was isolated from a pool of 
three thyroid lobes using TRIzol Reagent 
(Invitrogen Life Technologies) and reverse-
transcribed using Quantitec reverse transcription 
kit (Qiagen). qPCR reaction mixtures contained 
7,5 ng of total cDNA, Power PCR Master Mix 16 
(Applied Biosystems) and the following primers: 
Pax8, fw: GCCATGGCTGTGTAAGCAAGA, 
rev: GCTTGGAGCCCCCTATCACT; Titf1, fw: 
CTACTGCAACGGCAACCTG, rev: 
CCCATGCCATCATATATTCAT); Tg, fw: 
CATGGAATCTAATGCCAAGAACTG,  rev: 
TCCCTGTGAGCTTTTGGAATG; Tpo, fw: 
CAAAGGCTGGAACCCTAATTTCT, rev: 
AACTTGAATGAGGTGCCTTGTCA; Nis, fw: 
TCCACAGGAATCATCTGCA, rev: 
CCACGGCCTTCATACCACC; GAPDH, 
forward: AATGGTGAAGGTCGGTGTG, rev: 
GAAGATGGTGATGGGCTTCC; c-FLIP, fw: 
CCGTGAAGAGACTTACAGGA, rev: 
GTTATGTCATGTGACTTGGG; Bcl-2, fw: 
GGGGTCATGTGTGTGGAGAG,   rev:  
GCATGCTGGGGCCATATAGT;         Bfl-1/A1, 
fw: TGCCCTGGATGTATGTGCTT, rev:  
GAGCATTTCCCAGATCTGTC;        Bcl-xL, 
fw: CCTTGGATCCAGGAGAACGG, rev: 
AAGAGTGAGCCCAGCAGAAC;             
cIAP2, fw: AGAGAGGAGCAGATGGAGCA, 
rev: CCTGTTCAGTGATGGCCCTT;              
cIAP1, fw: GACCCCTGGATAGAACACGC, 
rev: CTGGGGTGTCTGAAGTGGAC; Xiap, fw:  
GGAACATGGACATCCTCAGT, rev:  
TACCACTTCGCATGCTGTTC;           RNA18S,  
fw: CGGCTACCACATCCAAGGAA,   rev: 
GGGCCTCGAAAGAGTCCTGT. Reactions 
were run on a 7900HT system (Applied 
Biosystems). For each sample, expression of the 
genes of interest was normalized on the 
expression of RNA18S and/or GAPDH measured 
under the same conditions (21). 
 
Culture of primary mouse thyrocytes  
Mice of different genotypes were anesthetized and 
sacrificed. Thyroid lobes were dissected 
aseptically and placed on a microscope slide 
containing a drop of Eagle’s minimum essential 
medium (EMEM). The lobes were disrupted 
mechanically, using two 25-gauge needles to 
obtain approximately ten fragments from each 
lobe. The fragments were transferred to a 1.5 ml 
tube containing 1 ml of digestion medium, 
consisting of 112 units/ml of type I collagenase 
(Sigma) and 1.2 units/ml of dispase dissolved in 
EMEM. The enzymatic digestion was carried out 
for 45 min in a 37°C water bath. The follicles 
were seeded and cultured in F12 medium 
(EuroClone) supplemented with 10% Nu-Serum 
IV (BD BioScience), 10 ng/ml somatostatin 
(Sigma Aldrich) and 2 ng/ml glycyl-L-histidyl-
lysine acetate (Sigma Aldrich) in a water-
saturated incubator, under air/CO2 (95%-5%) at 
37°C. TSH and TNFα used for thyrocytes 
stimulation were obtained from Sigma Aldrich. 
 
Free T4 and TSH measurement 
Venous blood samples were collected in 
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microtubes without anticoagulant. After clot 
formation, samples were centrifuged and the 
serum fraction was kept at -80°C. Free T4 was 
measured using the ELISA  kit from DiaMetra 
according to the manufacturer’s instructions. TSH 
levels were determined by rTSH (rat thyroid 
stimulating hormone) RIA kit (Institute of 
Isotopes, Budapest). 
 
MTT assay 
[3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl  
tetrazolium bromide] colorimetric assay for cell 
viability was performed in a 96-well flat-bottomed 
tissue culture plates as previously described (22). 
 
Statistics 
Data were analyzed by Student’s t-test. A p value 
< 0.05 was considered significant. 
 
RESULTS 
In order to understand the role of NEMO 
in thyroid development and function, we applied 
the Cre-LoxP strategy to specifically delete the 
NEMO locus in the thyroid gland. For this, 
females bearing a floxed NEMO allele 
(NEMOFlox/+), which do not show phenotype 
abnormalities (12), were crossed to the knock-in 
Pax8Cre/+ mice, which express the Cre 
recombinase under the control of the endogenous 
Pax8 gene promoter and mediate efficient Cre 
recombination in thyroid (18). Mutant mice were 
observed at the expected mendelian frequency, 
and were named NEMO thyroid-specific knock-
out (NEMOTS-KO). As shown in Fig. 1A, site-
specific recombination of the NEMO allele was 
observed only in NEMO floxed mice expressing 
the Cre recombinase. Efficient ablation of the 
NEMO locus was confirmed by immunoblot 
analysis on whole-thyroid extracts (Fig. 1B). 
Functional inactivation of the IKK complex was 
demonstrated by lack of I-κBα degradation in 
NEMOTS-KO thyrocytes following exposure to 
TNFα (Fig. 1C, left panel). On the other hand, 
expression of p65, IKKα/β  and p50  were not 
affected by genetic deletion of NEMO (Fig. 1C, 
right panel). As Pax8Cre/+ mice express Cre 
recombinase also in mesonephros and 
metanephros (18), excision of the NEMO floxed 
allele was consistently detected also in kidney 
tissues (Fig. 1D-E). 
NEMOTS-KO mutant mice appeared 
undistinguishable from control mice at birth (data 
not shown). In contrast, starting from two months 
of age, mutant mice developed clearly smaller 
than control littermates and displayed a 
significantly reduced body weight (Fig. 2A). 
NEMOTS-KO mice had a significantly shortened 
life span, and about 50% of mice die before 8 
months of age (Fig. 2B). When compared to 
control mice, NEMOTS-KO mice presented 
significantly lower levels of serum free T4 
hormone (Fig. 2C), and increased  thyroid 
stimulating hormone  (TSH) levels (Fig. 2D), 
which is indicative of hypothyroidism. Hence, 
body weight reduction and early lethality 
observed in these mice might be due, at least in 
part, to thyroid dysfunction. 
To exclude the possibility that the premature 
lethality observed in  NEMOTS-KO mice was due to 
renal failure, we carried out an histological and 
functional analysis on the kidneys of the mutant 
mice. The result of this analysis, shown in Table I, 
indicates that partial loss of NEMO expression in 
specific kidney tissues was not associated with an 
overt kidney phenotype. In fact, monitoring of the 
renal function in NEMOTS-KO mice did not reveal 
any physiological alteration (Table I). Kidney 
histology was assessed by H/E staining and 
immunohistochemistry for the kidney-specific 
markers AQP2 and NKCC2. Again, no alteration 
in immunoreactivity for these markers was 
detected in NEMOTS-KO  kidneys respect to control 
mice at 12 months of age (Figure 3A-C). From 
these results, we deduced that NEMOTS-KO  do not 
suffer of renal dysfunction. This conclusion is 
consistent with a previous observation showing 
that podocyte-specific NEMO-deficient mice do 
not show overt changes in kidney morphology and 
functionality (17). 
In order to verify whether NEMO 
inactivation affects thyroid embryonic 
development, mutant E16.5 embryos were 
analyzed, as Cre recombinase in Pax8Cre/+ mice is 
active from E8.5 (18). At E16.5 no alteration in 
thyroid size and morphology could be detected 
(Fig. 4A), and similar results were obtained when 
the same analysis was performed in mice at 1 
month of age (Fig. 4A). Hence, these data indicate 
that canonical NF-κB signaling is not required for 
embryonic thyroid development and 
differentiation. 
The effect of NEMO conditional inactivation on 
thyroid morphology and differentiation was 
further analyzed. Starting from 2 months of age, 
thyroid glands of NEMOTS-KO mice appear 
considerably smaller compared to control mice 
(Fig. 4B). In the surviving 2-month-old NEMOTS-
KO mice, significant cell loss is observed, and the 
thyroid follicular architecture appears highly 
variable in diameter with irregular outlines (Fig. 
4B-F). Immunohistochemical and 
immunofluorescent analysis  shows that  
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expression level of two thyroid-specific 
transcription factors, namely Pax8 and Ttf1, 
steadily declines over time (Fig. 4 CD). Similarly 
occurs for thyroglobulin and for the Na/I 
symporter Nis (Fig. 4E-F). Nis, for instance, 
appears barely detectable in thyrocytes isolated 
from  two-month-old NEMOTS-KO mice (Fig. 4E). 
Masson's trichrome staining also revealed the 
presence of fibrotic material in mutant thyroids 
(Fig. 4G). In all staining, it was clearly visible the 
progressive disorganization and degeneration of 
the thyroid parenchyma in NEMOTS-KO mutant 
mice.  Also, reduction of cellularity and gland size 
in  NEMOTS-KO  mice is accompanied with 
massive apoptosis, as indicated by the staining for 
active caspase 3 (Fig. 4H). 
qPCR analysis confirmed the reduced expression 
of  the thyroid markers Pax8, Ttf1, Tpo and Nis in 
NEMO-deleted thyroids (Fig. 4I). The mRNA 
expression level of TSH receptor and 
thyroglobulin were also both significantly reduced 
(Fig. 4I). Despite its reduced expression, however, 
TSH receptor signaling does not appear 
compromised in NEMOTS-KO thyrocytes, as 
assessed by monitoring phosphorylation of CREB 
following TSH stimulation  (Fig. 4J). 
 
NF-κB controls the expression of several genes, 
including Bfl-1/A1, Bcl-2, Bcl-xL, c-FLIP and 
IAPs, that protect cells against apoptotic cell death 
(23-29). Consistently, all these anti-apoptotic 
genes appear significantly down regulated in 
NEMO-deficient thyrocytes  (Fig. 5A).  Thus, we 
verified whether NEMOTS-KO thyrocytes exhibit a 
greater sensitivity to apoptotic stimuli. As shown 
in Fig. 5 B-E, lack of NEMO dramatically 
sensitizes these thyrocytes to the cytotoxic action 
of both TNFα and TSH.   
 
Taken together, these data demonstrate that in 
adult mice NEMO is required for thyrocytes 
survival and contributes to the maintenance of 
thyrocyte differentiation by regulating the 
expression of several thyroid markers. 
 
DISCUSSION 
In this paper, we demonstrate that NEMO 
signaling is essential for normal postnatal thyroid 
gland structure and function. Although previous 
studies have clearly established a role for NF-κB 
in thyroid tumors progression (25-27), this is the 
first work that examines the role of canonical NF-
κB signaling in normal thyroid development and 
physiology. We show that mice with thyroid-
specific ablation of NEMO develop a pronounced 
impairment of thyroid function, eventually leading 
to shortened life span. On the other hand, no gross 
alterations of thyroid gland localization, 
morphology and differentiation were observed 
during embryonic development and in newborn 
mice, indicating that the NEMO-dependent NF-
κB signaling is not required for embryonic thyroid 
development. Our results indicate that in thyroid 
NEMO is required for at least two essential 
aspects, that are: i) thyrocytes survival and, ii) 
maintenance of thyroid markers expression. The 
critical role of NF-κB in cell survival is widely 
supported by the available literature. Gene-
targeting experiments have in fact shown that 
mice lacking p65/RelA, IKK2, or NEMO die 
during embryonic development due to liver 
apoptosis (7-12). Thus, the extensive apoptosis 
observed in NEMOTS-KO thyrocytes confirms the 
requirement for NF-κB in orchestrating 
cytoprotective pathways. Particularly interesting 
is the data showing the different behavior of wt 
and NEMOTS-KO thyrocytes when exposed to TSH. 
In fact, while both wild type and NEMOTS-KO 
thyrocytes proliferate following TSH stimulation, 
NEMOTS-KO thyrocytes also undergo extensive 
apoptosis (Fig. 5). This finding is consistent with 
a previous evidence showing that TSH stimulation 
on thyrocytes in fact triggers both proliferative 
and apoptotic responses (33). Our work now 
shows that NF-κB signaling could play a decisive 
role in determining the fate of thyrocytes 
following TSH stimulation. 
An interesting aspect of our experiments is the 
evidence here provided that NF-κB controls, 
directly or indirectly, the expression level of 
several thyroid markers. Although an involvement 
of NF-κB in the regulation of Nis expression has 
been already reported (34), we now show that, in 
addition to Nis, NF-κB controls the expression of 
a panel of thyroid markers, including Ttf1, Pax8, 
Tpo and thyroglobulin. In this context, our work 
provides a molecular explanation for some 
phenotypical aspects of human disorders 
associated with mutations in NEMO. In humans, 
in fact, mutations in the X-linked NEMO gene 
cause two distinct genetic diseases. Mutations that 
completely disrupt the NEMO locus result in 
Incontinentia Pigmenti, a disease where male 
patients die in utero, whereas the phenotypic 
analysis of females is complicated by the fact that 
NEMO-deficient cells quickly disappear and are 
replaced by wild-type cells. A second disease, 
named hypohydrotic ectodermal dysplasia with 
immune deficiency (HED-ID), is characterized by 
hypomorphic NEMO mutations that do not 
completely abolish but rather reduce NF-κB 
activation. HED-ID is characterized by impaired 
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skin appendage development and severe immune 
deficiency. Strikingly, hypothyroidism is not 
uncommon in patients with HED-ID (35-38), as 
predicted by the data we show here.  
In conclusion, our data can be easily interpreted 
considering the crucial role that NEMO plays in 
activation of NF-κB which, in turn, regulates the 
expression of genes that are critical for cell 
survival. However, it should not be disregarded 
that NF-κB-independent  functions  have been 
ascribed to NEMO, and these latter are as well 
involved in the control of  cell proliferation and 
cell death (39-41). Hence, it is well possible  that 
NF-κB-independent  functions  of NEMO may 
contribute, at least in part, to the cellular 
degeneration observed in NEMOTS-KO  thyrocytes. 
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FIGURE LEGENDS 
 
Table I Renal physiology parameters in NEMOTS-KO mice. 
 
Figure 1 Generation of thyroid-specific NEMO knockout mice. A) PCR analysis of thyroid genomic DNA 
extracted from one-month-old mice of the indicated genotypes. For amplification of NEMO alleles, two 
different primer sets were used, one amplifying the floxed region, and the other amplifying the allele 
resulting from excision (12). Pax8-Cre allele were amplified with a primer set enabling to distinguish the 
Cre-encoding  allele from the wild-type allele. B) Thyroid extracts from 8-week-old NEMOTS-KO mice and 
littermate control mice were analyzed by immunoblot assay. Actin blot served as loading control. C) Protein 
extracts prepared from NEMOTS-KO and wild-type cultured thyrocytes at the indicated time points after TNFα 
stimulation (10ng/ml)  were assessed for I-κBα degradation (left panel) and expression of components of the 
NF-κB pathway (right panel) by immunoblot analysis. D-E) Genomic and immunoblot analysis in the 
kidney cortex, inner stripe of the outer medulla (ISOM) and inner medulla (IM) of NEMOTS-KO and control 
mice. 
 
Figure 2 Early lethality of NEMOTS-KO mice A) Body weight of male NEMOTS-KO and control mice at one 
month after birth (n = 12 for each genotype). p value was calculated with Student’s t-test comparing both 
groups. B) Survival rates of NEMOTS-KO and control mice (n = 10 for each) during 12 months after birth. C) 
ELISA assay of free T4  serum level in NEMOTS-KO and control mice (n = 10 for each group) at  the indicated  
months after birth. D) TSH serum level in NEMOTS-KO and control mice at 12 months after birth (n = 7 
 for each group). 
 
Figure 3 NEMOTS-KO mice kidney phenotype analysis. A) Hematoxylin and eosin (H&E) staining and B) 
immunohistochemical analysis of the kidney markers NKCC2 and AQP2 in control and NEMOTS-KO kidney 
sections at 12 months of age (OM, outer medulla; IM, inner medulla). C) Quantification of AQP2 positive 
cells in the collecting ducts (CD) of the inner medulla. Count was carried out on images acquired from 5 
NEMOTS-KO and 5 control mice. Data shown is representative of at least three independent experiments. 
 
Figure 4 Down-regulation of thyroid markers and apoptosis in NEMOTS-KO thyroid. Hematoxylin and eosin  
staining (A, B) and immunohistochemical analysis of C) Pax8, D) Ttf1, F) thyroglobulin  and H) active 
caspase 3  in control and NEMOTS-KO thyroid sections at the indicated age. G) Masson’s trichromic staining 
in NEMOTS-KO and control thyroids. Fibrotic material appears as a blue staining (black arrows). E) 
Immunofluorescence analysis of Nis in NEMOTS-KO and control mice. I) Left panel Quantitative PCR 
expression analysis of the indicated genes in thyroids isolated from NEMOTS-KO and control mice at 12 
months of age. Each RNA sample was obtained by pooling three thyroids/genotype. Data shown (mean + 
SEM, n = 3) is representative of at least three independent experiments done in triplicate.  Right panel 
Immunoblot analysis of thyroid markers in thyrocytes isolated from NEMOTS-KO and control mice. J)  
Western blot analyses of total and phosphorylated CREB in protein extracts from NEMOTS-KO and control 
thyrocytes left untreated or stimulated with TSH (1%mU/ml) for 30 min. 
 
Figure 5 Increased sensitivity of NEMOTS-KO thyrocytes to apoptosis. A) Quantitative PCR expression 
analysis of the indicated anti-apoptotic genes in thyrocytes isolated from 12-month-old  NEMOTS-KO and 
control mice left untreated or stimulated with TNFα (10ng/ml) for 7 hrs. Each RNA sample was obtained by 
pooling three thyroids/genotype. Data shown (mean + SEM, n = 3) is representative of at least three 
independent experiments done in triplicate.  B) Thyrocytes from six-month-old NEMOTS-KO and wild type 
mice were left untreated or treated with TNFα (10ng/ml) or TSH (1 mU/ml) for 24 hrs, and cell viability was 
measured by MTT assay. Data shown (mean + SEM, n = 3) is representative of at least three independent 
experiments done in triplicate.  C) Phase-contrast micrographs of thyreocytes treated as in B). D) 
Immunoblot assay of caspase 3 from proteic lysates of thyreocytes treated as in B). Activation of caspase 3 
can be inferred from processing of the p32 precursor. E) Immunoblot assay (left panel) and its 
densitomentric analysis (right panel) of NEMO expression in purified thyrocytes used for the experiments 
shown above. Data shown is representative of at least three independent experiments. 
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TABLE I 
 
12-month-old mice NEMOTS-KO n. CTR n p val. NEMOTS-KO vs. CTR 
Weight gr 26.25 ±  0.77 14 30.02 ± 1.06 11 0.0037 
Urine Output µl/min/gbw 52.74 ± 4.31 11 46.05 ± 4.50 9 0.454 
Proteinuria mg/24hrs 2.1 ± 0.25 11 1.94 ± 0.22 9 0.65 
Urinary pH pH 7.03 ± 0.39 7 7.06 ±  0.40 7 0.95 
Na/Creatinine mM/mM 36.8 ± 2.76 10 32.28 ±  2.24 9 0.23 
K/Creatinine mM/mM 49 ± 3.82 10 37.59 ±  4.63 9 0.07 
Cl/Creatinine mM/mM 74 ± 3.63 10 73.36 ±  3.48 9 0.89 
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